Advanced search: Search from
Select basic information for advanced search
| Free word |
|---|
| Copy service |  |
|---|---|
| Related links |  |
| Publisher site |  |
Art
J-GLOBAL ID：200902249279008340
Reference number：09A0914028 Molecular bases and therapeutic strategies of defective neuromuscular transmissions: Lessons learned from a prototypical synapse.
プロタイプシナプスとしての神経筋接合部の病態と治療戦略
ClipsReference (26)
- BEESON, D. Dok-7 mutations underlie a neuromuscular junction synaptopathy. Science. 2006, 313, 1975-1978
- BIAN, Y. Tannic acid facilitates expression of the polypyrimidine tract binding protein and alleviates deleterious inclusion of CHRNA1 exon P3A due to an hnRNP H-disrupting mutation in congenital myasthenic syndrome. Hum Mol Genet. 2009, 18, 1229-1237
- CHEVESSIER, F. MUSK, a new target for mutations causing congenital myasthenic syndrome. Hum Mol Genet. 2004, 13, 3229-3240
- ENGEL, A. G. Sleuthing molecular targets for neurological diseases at the neuromuscular junction. Nat Rev Neurosci. 2003, 4, 339-352
- FUKUDOME, T. Quinidine normalizes the open duration of slow-channel mutants of the acetylcholine receptor. Neuroreport. 1998, 9, 1907-1911
- HARPER, C. M. Treatment of slow-channel congenital myasthenic syndrome with fluoxetine. Neurology. 2003, 60, 1710-1713
- KIMBELL, L. M. C-terminal and heparin-binding domains of collagenic tail subunit are both essential for anchoring acetylcholinesterase at the synapse. J Biol Chem. 2004, 279, 10997-11005
- MASUDA, A. HnRNP H enhances skipping of a nonfunctional exon P3A in CHRNA1 and a mutation disrupting its binding causes congenital myasthenic syndrome. Hum Mol Genet. 2008, 17, 4022-4035
- MILONE, M. Mode switching kinetics produced by a naturally occurring mutation in the cytoplasmic loop of the human acetylcholine receptor εsubunit. Neuron. 1998, 20, 575-588
- OHNO, K. Congenital myasthenic syndromes : Genetic defects of the neuromuscular junction. Curr Neurol Neurosci Rep. 2002, 2, 78-88
- OHNO, K. Lack of founder haplotype for the rapsyn N88K mutation : N88K is an ancient founder mutation or arises from multiple founders. J Med Genet. 2004, 41, e8
- OHNO, K. Congenital myasthenic syndrome caused by prolonged acetylcholine receptor channel openings due to a mutation in the M2 domain of the ε subunit. Proc Natl Acad Sci USA. 1995, 92, 758-762
- OHNO, K. Congenital myasthenic syndrome caused by decreased agonist binding affinity due to a mutation in the acetylcholine receptor ε subunit. Neuron. 1996, 17, 157-170
- OHNO, K. Congenital myasthenic syndromes due to heteroallelic nonsense/missense mutations in the acetylcholine receptor ε subunit gene : Identification and functional characterization of 6 new mutations. Hum Mol Genet. 1997, 6, 753-766
- OHNO, K. Human endplate acetylcholinesterase deficiency caused by mutations in the collagen-like tail subunit (ColQ) of the asymmetric enzyme. Proc Natl Acad Sci USA. 1998, 95, 9654-9659
- OHNO, K. Myasthenic syndromes in Turkish kinships due to mutations in the acetylcholine receptor. Ann Neurol. 1998, 44, 234-241
- OHNO, K. Congenital end-plate acetylcholinesterase deficiency caused by a nonsense mutation and an A>G splice-donor-site mutation at position +3 of the collagenlike-tail-subunit gene (COLQ) : How does G at position +3 result in aberrant splicing?. Am J Hum Genet. 1999, 65, 635-644
- OHNO, K. The spectrum of mutations causing endplate acetylcholinesterase deficiency. Ann Neurol. 2000, 47, 162-170
- OHNO, K. Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans. Proc Natl Acad Sci USA. 2001, 98, 2017-2022
- OHNO, K. Rapsyn mutations in humans cause endplate acetylcholine receptor deficiency and myasthenic syndrome. Am J Hum Genet. 2002, 70, 875-885
Return to Previous Page
